Research team affirms useful blood biomarker for group of brain disorders in new study
Smartwatches and fitness bands reveal individual physiological responses to COVID-19 vaccine
19 April 2022When severe infection causes long-term mood disorders: Researchers identify promising treatment path
20 April 2022Research team affirms useful blood biomarker for group of brain disorders in new study
A test of protein in the blood is receiving further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders with few treatment options. These disorders are characterized by changes in behavior, cognition, language or movement.
